Interdisciplinary collaboration
Access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education
Excellence in Scientific Discovery
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Research Programs
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
Shared Resources
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Seminars
Ongoing seminars allow cancer specialists to share knowledge and foster new collaborations.
Institute Membership
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Clinical Trial Support
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Funding Opportunities
Internal and external sources of support for both established cancer research programs and promising new ideas.
News & Publications
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Training Opportunities
Education and professional development designed to train the next generation of cancer researchers and physicians.
National Cancer Institute Designation
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
News & Publications
-
Brain tumor growth stopped
High-grade gliomas, a group of aggressive brain tumors, cease growing in mice if a signaling molecule called neuroligin-3 is absent or its activity is blocked with drugs, a Stanford team has shown.
-
Gift establishes cancer cell therapy center
Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke, have provided funding for a new venture at Stanford Medicine to test cancer cell therapies.
-
Helping women identify their risk for cancer
Researchers assigned levels of risk to 25 mutations associated with breast and ovarian cancer in a large, Stanford-led study. The results may be helpful in guiding treatment and screening recommendations.
